Morange PE - Search Results

1

Comparison of omeprazole and pantoprazole influence on a high 150-mg clopidogrel maintenance dose the PACA (Proton Pump Inhibitors And Clopidogrel Association) prospective randomized study.

Cuisset T, Frere C, Quilici J, Poyet R, Gaborit B, Bali L, Brissy O, Morange PE, Alessi MC, Bonnet JL. Cuisset T, et al. Among authors: morange pe. J Am Coll Cardiol. 2009 Sep 22;54(13):1149-53. doi: 10.1016/j.jacc.2009.05.050. J Am Coll Cardiol. 2009. PMID: 19761935 Free article. Clinical Trial.

2

Production of plasminogen activator inhibitor 1 by human adipose tissue: possible link between visceral fat accumulation and vascular disease.

Alessi MC, Peiretti F, Morange P, Henry M, Nalbone G, Juhan-Vague I. Alessi MC, et al. Diabetes. 1997 May;46(5):860-7. doi: 10.2337/diab.46.5.860. Diabetes. 1997. PMID: 9133556

3

Fibrinogen, obesity and insulin resistance.

Juhan-Vague I, Morange P, Renucci JF, Alessi MC. Juhan-Vague I, et al. Blood Coagul Fibrinolysis. 1999 Feb;10 Suppl 1:S25-8. Blood Coagul Fibrinolysis. 1999. PMID: 10070814 Review. No abstract available.

4

Glucocorticoids and insulin promote plasminogen activator inhibitor 1 production by human adipose tissue.

Morange PE, Aubert J, Peiretti F, Lijnen HR, Vague P, Verdier M, Négrel R, Juhan-Vague I, Alessi MC. Morange PE, et al. Diabetes. 1999 Apr;48(4):890-5. doi: 10.2337/diabetes.48.4.890. Diabetes. 1999. PMID: 10102708

5

PAI-1 produced ex vivo by human adipose tissue is relevant to PAI-1 blood level.

Morange PE, Alessi MC, Verdier M, Casanova D, Magalon G, Juhan-Vague I. Morange PE, et al. Arterioscler Thromb Vasc Biol. 1999 May;19(5):1361-5. doi: 10.1161/01.atv.19.5.1361. Arterioscler Thromb Vasc Biol. 1999. PMID: 10323791

6

Relationship of plasminogen activator inhibitor-1 levels following thrombolytic therapy with rt-PA as compared to streptokinase and patency of infarct related coronary artery.

Paganelli F, Alessi MC, Morange P, Maixent JM, Lévy S, Vague IJ. Paganelli F, et al. Thromb Haemost. 1999 Jul;82(1):104-8. Thromb Haemost. 1999. PMID: 10456462 Clinical Trial.

7

Influence of PAI-1 on adipose tissue growth and metabolic parameters in a murine model of diet-induced obesity.

Morange PE, Lijnen HR, Alessi MC, Kopp F, Collen D, Juhan-Vague I. Morange PE, et al. Arterioscler Thromb Vasc Biol. 2000 Apr;20(4):1150-4. doi: 10.1161/01.atv.20.4.1150. Arterioscler Thromb Vasc Biol. 2000. PMID: 10764686

8

The A -844G polymorphism in the PAI-1 gene is associated with a higher risk of venous thrombosis in factor V Leiden carriers.

Morange PE, Henry M, Tregouët D, Granel B, Aillaud MF, Alessi MC, Juhan-Vague I. Morange PE, et al. Arterioscler Thromb Vasc Biol. 2000 May;20(5):1387-91. doi: 10.1161/01.atv.20.5.1387. Arterioscler Thromb Vasc Biol. 2000. PMID: 10807758

9

Plasma TAFI antigen variations in healthy subjects.

Chetaille P, Alessi MC, Kouassi D, Morange PE, Juhan-Vague I. Chetaille P, et al. Among authors: morange pe. Thromb Haemost. 2000 Jun;83(6):902-5. Thromb Haemost. 2000. PMID: 10896246

10

Plasminogen activator inhibitor 1, transforming growth factor-beta1, and BMI are closely associated in human adipose tissue during morbid obesity.

Alessi MC, Bastelica D, Morange P, Berthet B, Leduc I, Verdier M, Geel O, Juhan-Vague I. Alessi MC, et al. Diabetes. 2000 Aug;49(8):1374-80. doi: 10.2337/diabetes.49.8.1374. Diabetes. 2000. PMID: 10923640

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

293 results

Search Page